Emmitt Smith and Emergent BioSolutions Promote Opioid Awareness
Emergent BioSolutions Collaborates with Emmitt Smith for Awareness
In a touching collaboration, Emergent BioSolutions Inc. is joining forces with football icon Emmitt Smith to shine a spotlight on the Ready to Rescue campaign. While recent reports showcase a national decline in opioid overdose deaths, the reality on the ground tells a different story in many communities. New Orleans, for example, continues to witness an alarming rise in accidental drug-related fatalities year over year.
Educational Outreach in New Orleans
The initiative includes the impactful 'Lay, Spray, Stay' educational video, featuring Smith, which aims to inform viewers on the proper use of NARCAN Nasal Spray to combat opioid overdoses. This vital content will be prominently displayed on local taxi television screens throughout New Orleans.
NARCAN Nasal Spray Distribution
To further amplify their message, Emergent plans to distribute hundreds of NARCAN Nasal Spray cartons to individuals during the weekend. This distribution, alongside the educational campaign, aims to prepare the community for potential opioid emergencies that can happen to anyone, anywhere, at any time.
Empowering Communities Against Opioid Emergencies
Emergent BioSolutions has committed to enhancing community preparedness against opioid emergencies. With over 83,000 fans expected to flock to New Orleans for a critical sporting event, the timing of this campaign is especially crucial. Over the last two years, Emmitt Smith has dedicated himself to raising awareness about the opioid crisis, sharing his personal story to help reduce the stigma surrounding opioid poisonings and encouraging communities to take action.
Significance of the Campaign
Statistics from the Centers for Disease Control and Prevention illustrate a remarkable national reduction in opioid overdose deaths for the first time in five years. Nonetheless, the fight is far from over, as many cities, including New Orleans, see a troubling increase in accidental drug-related deaths. In 2022, data indicated that drug-related overdose deaths in New Orleans were nearly double that of homicides, emphasizing the need for ongoing education about opioid overdose risks and NARCAN availability.
Educational Campaign Priorities
Emergent's campaign with Smith focuses on the straightforward, life-saving process of administering NARCAN using the three steps: Lay, Spray, and Stay. Smith will also engage with both national and local media to discuss the importance of NARCAN, highlighting its ability to reverse the effects of opioid poisoning swiftly, and its availability over the counter, empowering everyone to be part of the solution.
Quotes from Leadership
“New Orleans will be a focal point this weekend. Our goal is to trigger important conversations about opioid emergencies, as we utilize this pivotal moment to promote awareness around NARCAN Nasal Spray,” stated Paul Williams, Senior Vice President at Emergent. “Our dedication to alleviating the opioid overdose crisis remains steadfast; we believe that accessible NARCAN Nasal Spray, coupled with our collaborations with government entities, advocacy groups, and retail partners, is vital in preparing communities for emergencies.”
About NARCAN Nasal Spray
NARCAN Naloxone HCl Nasal Spray, at 4 mg, is the first FDA-approved, over-the-counter naloxone product specifically formulated for emergency treatment of opioid overdose. It is important to note that NARCAN is not intended to replace emergency medical care, and repeated doses may be necessary depending on the severity of the overdose.
About Emergent BioSolutions
Emergent BioSolutions has spent more than 25 years safeguarding public health, delivering solutions designed to combat urgent health threats through innovative vaccines and therapeutics. With a vision to protect and enhance the lives of one billion individuals by 2030, Emergent remains committed to developing services that support both government and consumer needs while forging a path toward a healthier community.
Frequently Asked Questions
What is the aim of the Ready to Rescue campaign?
The campaign aims to raise awareness about opioid overdoses and educate communities on using NARCAN Nasal Spray effectively.
Who is Emmitt Smith in relation to the campaign?
Emmitt Smith is a paid spokesperson for Emergent BioSolutions and actively raises awareness about opioid-related issues through this campaign.
What areas are particularly affected by opioid overdoses?
Many U.S. communities, including New Orleans, are experiencing increased rates of accidental drug-related deaths, despite recent national declines.
How can I get NARCAN Nasal Spray?
NARCAN Nasal Spray is available over the counter, allowing individuals to access it easily for emergency situations.
Why is this campaign significant during the Big Game?
With thousands of fans expected in New Orleans, this campaign leverages the cultural moment to initiate discussions on opioid emergencies and preparedness.
About The Author
Contact Olivia Taylor privately here. Or send an email with ATTN: Olivia Taylor as the subject to contact@investorshangout.com.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.
